Verseon has assembled a talented team of scientists and engineers with expertise in physics, mathematics, medicinal and synthetic chemistry, biology, computer science, and early-stage drug discovery.

Senior team members are: 

Adityo Prakash, Founder, CEO: Experienced in bringing breakthrough technologies to market; co-founder and former CEO of Pulsent Corp.; inventor on 35 patents; BS, California Institute of Technology

Eniko Fodor, Founder, COO : Experienced in building cutting-edge technology organizations with highly effective operating, marketing, and IP strategies; co-founder and former COO of Pulsent Corp.; inventor on 17 patents; BS, Universitatea Babes-Bolyai, Romania 

David Kita, Founder, Vice President of R&D: Experienced in developing technological solutions in molecular modeling, bioinformatics, and signal processing; former Director of R&D of Pulsent Corp. and Director of Software and Algorithm Development – Bioinformatics at Hyseq Inc; inventor on 16 patents; Ph.D., University of Wisconsin, Madison

David Williams, Senior Director of Platform Technology: Experienced in running successful computational physics and chemistry programs; led large research teams in high-energy physics simulations at the Stanford Linear Accelerator Center (SLAC); Ph.D., Massachusetts Institute of Technology

Anirban Datta, Senior Director of Discovery Biology: Experienced in cancer cell biology, biochemistry, and novel bio-assay development; elucidated signaling in cancer metastasis at UCSF; co-founded and led development of 3-D cell-culture assays at Pharmacomatrix Inc.; Ph.D., University of Pennsylvania

Proprietary Platform

Consistently designs novel drug candidates that are unlikely to be found using conventional methods

 

Drug Programs

Multiple therapeutic areas, all with unmet (or poorly met) medical needs